Skip to content

License Reinstated for Canadian Pharmacist Who Sold Counterfeit Cancer Drugs to the US

Canadian internet pharmacist Kristjan Thorkelson had his license reinstated by the College of Pharmacists of Manitoba only days after the regulatory authority suspended him, according to a report by CBC News. The sudden reversal reinforces LegitScript's assertion that Canadian regulation of these internet pharmacies is inadequate for protecting US consumers.

The Canadian regulatory authority confirmed to CBC News that the sanction was lifted in late December 2017 but offered no additional details. Thorkelson, who is the president of CanadaDrugs.com, had his license suspended less than a week previous because, according to the College's Complaint Committee, "his conduct presents or is likely to present a serious risk to the public."

Canadian rogue internet pharmacies such as CanadaDrugs use the defense that Canadian regulation is sufficient to protect consumers, both in the country where they operate and in other jurisdictions, such as the US. But the lightning speed with which Thorkelson's license was reinstated illustrates just how impotent these regulations are in safeguarding US consumers. Because CanadaDrugs didn't commit a violation of Canadian law and didn't harm Canadian citizens, regulatory authorities in that country have little cause or means to sanction the operator, even for crimes as egregious as selling counterfeit drugs.

In 2017, Thorkelson and five others were arrested last year and extradited to the United States for selling fake cancer drugs online. US federal prosecutors accused the men of illegally importing and selling $78 million worth of unapproved, misbranded, and counterfeit drugs to the US between 2009 and 2012.

Under a tentative plea agreement, which was detailed in US court documents filed in late December, Thorkelson would pay a $250,000 fine and serve six months of house arrest, followed by four and a half years of probation. The plea agreement would also have CanadaDrugs and two subsidiaries plead guilty, pay a $5 million fine, and forfeit $29 million. Were Thorkelson tried and convicted, he could face up to 20 years in prison.

According to CBC News, the presiding judge in a US district court in Montana must still accept the plea agreement. A date for that proceeding has been set for April 2018.

 

David Khalaf is a writing, communications, and marketing professional with specialties in media, investigations, content strategy, and writing instruction. His 20 years of writing, media, and communications work have included two top-tier universities (USC and UCLA), print and digital magazines, consulting firms, and technology companies.

His current work involves content strategy and development at LegitScript, a company that helps the world's leading search engines, payment service providers, and internet platforms and marketplaces do business with legitimate, legally operating entities in more than 80 countries and 15 languages around the world. LegitScript specializes in risk and compliance for highly regulated industries including CBD/cannabis, online gambling, cryptocurrencies, drugs, financial trading, online adult, scams and fraud, and more.

Recent Blog Articles

This Is How Addiction Treatment Providers in Canada Can Now Get LegitScript-Certified

For the first time, Canadian addiction treatment providers are eligible to become LegitScript-certified and advertise their services on Google to more effectively reach individuals in search of recovery. In Canada, as in the United States, substance use disorder remains a pervasive problem that impa...
merchant risk

The Challenges and Opportunities of Quantifying Merchant Risk

Merchant risk management is a dynamic and ever-evolving field with challenges ranging from fraud prevention to regulatory compliance. LegitScript hosted a webinar featuring industry experts Chiat Fitzgerald, former Head of Global Ecosystem Security & Integrity at Visa, and Caroline Hometh, Manag...
weight loss drugs

LegitScript Gives You the Skinny on New Weight Loss Drugs

GLP-1 receptor agonists are revolutionizing treatments for weight-related illnesses like diabetes and obesity. Originally developed to mimic the GLP-1 hormone that regulates blood sugar and appetite, drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have gained widespread acclaim f...
LegitScript Enterprise Certification

LegitScript Enterprise Certification is a Premium Service—Here’s Why

LegitScript certification services represent a recognized seal of approval that enables businesses to showcase their compliance, unlock opportunities to advertise, and accept digital payments. Certification also helps businesses demonstrate that they adhere to the highest standards of care-building...